基本信息
文件名称:RSK-IN-2-生命科学试剂-MCE.pdf
文件大小:462.32 KB
总页数:1 页
更新时间:2025-06-12
总字数:约2.19千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

RSK-IN-2

Cat.No.:HY-173406

CASNo.:3011713-80-4

分?式:C??H??ClN?O?

分?量:512

作?靶点:RibosomalS6Kinase(RSK);Apoptosis

作?通路:MAPK/ERKPathway;Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性RSK-IN-2(Compound3e)是RSK的抑制剂,其IC50分别为37.89nM(RSK2)、30.78nM(RSK1)、20.51nM

(RSK3)和91.28nM(RSK4)。RSK-IN-2抑制肿瘤细胞增殖,诱导细胞凋亡(Apoptosis),并导致细胞周期停滞于

G2/M期。

IC50TargetRSK1RSK2RSK3RSK4

30.78nM(IC50)37.89nM(IC50)20.51nM(IC50)91.28nM(IC50)

REFERENCES

[1].HanC,etal.Discoveryof2,4-dianilinopyrimidinederivativesasnovelp90ribosomalS6proteinkinase(RSK)inhibitors.EurJMed

Chem.2025Jul5;291:117590.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021